These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Long-term therapy of myoclonus and other neurologic disorders with L-5-hydroxytryptophan and carbidopa. Van Woert MH; Rosenbaum D; Howieson J; Bowers MB N Engl J Med; 1977 Jan; 296(2):70-5. PubMed ID: 401457 [TBL] [Abstract][Full Text] [Related]
3. Treatment of myoclonic syndromes with paroxetine alone or combined with 5-HTP. Magnussen I; Mondrup K; Engbaek F; Lademann A; Olivarius BD Acta Neurol Scand; 1982 Aug; 66(2):276-82. PubMed ID: 6215817 [No Abstract] [Full Text] [Related]
4. Functional independence in post-anoxic myoclonus: contribution of L-5-HTP sodium valproate and clonazepam. Carroll WM; Walsh PJ Br Med J; 1978 Dec; 2(6152):1612. PubMed ID: 365292 [No Abstract] [Full Text] [Related]
5. Therapy of intention myoclonus with L-5-hydroxytryptophan and a peripheral decarboxylase inhibitor, MK 486. Van Woert MH; Sethy VH Neurology; 1975 Feb; 25(2):135-40. PubMed ID: 1078720 [TBL] [Abstract][Full Text] [Related]
6. [Utilization of levo-5-hydroxytryptophan in post-anoxic myoclonus]. Rascol A; Guiraud-Chaumeil B; Laboucarie J; Montastruc JL; El-Hage W Therapie; 1978; 33(5):623-8. PubMed ID: 311085 [No Abstract] [Full Text] [Related]
7. Postanoxic myoclonus. Treatment of a case with 5-hydroxytryptophane and a decarboxylase inhibitor. Beretta E; Regli F; de Crousaz G; Steck AJ J Neurol; 1981; 225(1):57-62. PubMed ID: 6164757 [TBL] [Abstract][Full Text] [Related]
8. The effect of intravenous L-5-HTP in the myoclonic encephalopathy of infants. Gobbi G; Melideo G; Giovanardi Rossi P Neuropediatrics; 1986 May; 17(2):63-5. PubMed ID: 3014368 [TBL] [Abstract][Full Text] [Related]
10. Clinical, biochemical, and physiological features distinguishing myoclonus responsive to 5-hydroxytryptophan, tryptophan with a monoamine oxidase inhibitor, and clonazepam. Chadwick D; Hallett M; Harris R; Jenner P; Reynolds EH; Marsden CD Brain; 1977 Sep; 100(3):455-87. PubMed ID: 412560 [TBL] [Abstract][Full Text] [Related]
11. Treatment of posthypoxic action myoclonus: implications for the pathophysiology of the disorder. Chadwick D; Hallett M; Jenner P; Marsden CD Adv Neurol; 1986; 43():183-90. PubMed ID: 2418645 [No Abstract] [Full Text] [Related]
12. Myoclonus. Marsden CD Mod Trends Neurol; 1975; 6():321-2. PubMed ID: 1105145 [No Abstract] [Full Text] [Related]
13. Successful treatment of cherry red spot-myoclonus syndrome with 5-hydroxytryptophan. Gascon G; Wallenberg B; Daif AK; Ozand P Ann Neurol; 1988 Sep; 24(3):453-5. PubMed ID: 3265864 [TBL] [Abstract][Full Text] [Related]
14. Clinical, biochemical, and pharmacological observation in a patient with postasphyxic myoclonus: association to serotonin hyperactivity. Giménez-Roldán S; Mateo D; Muradas V; De Yebenes JG Clin Neuropharmacol; 1988 Apr; 11(2):151-60. PubMed ID: 2454156 [TBL] [Abstract][Full Text] [Related]